ArticleNeuro-oncology2011

AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

Matthew L Bush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.